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Crystalline silica (cSiO2 ) is a widely recognized environmental trigger of autoimmune
disease. In the lupus-prone female NZBWF1 mouse, airway exposure to cSiO2
triggers pulmonary ectopic lymphoid neogenesis, systemic autoantibody elevation,
and glomerulonephritis. Here we tested the hypothesis that upregulation of adaptive
immune function genes in the lung precedes cSiO2 -triggering of autoimmune
disease in this model. The study include three groups of mice, as follows: (1)
necropsied 1 d after a single intranasal instillation of 1 mg cSiO2 or vehicle, (2)
necropsied 1 d after four weekly single instillations of 1 mg cSiO2 or vehicle, or (3)
necropsied 1, 5, 9, or 13 weeks after four weekly single instillations of 1 mg cSiO2
or vehicle. NanoString nCounter analysis revealed modest transcriptional changes
associated with innate and adaptive immune response as early as 1 d after a
single cSiO2 instillation. These responses were greatly expanded after four weekly
cSiO2 instillations. Concurrent with ectopic lymphoid neogenesis, dramatic increases in
mRNAs associated with chemokine release, cytokine production, sustained interferon
activity, complement activation, and adhesion molecules were observed. As disease
progressed, expression of these genes persisted and was further amplified. Consistent
with autoimmune pathogenesis, the time between 5 and 9 weeks post-instillation
reflected an important transition period where considerable immune gene upregulation
in the lung was observed. Upon termination of the chronic study (13 weeks),
cSiO2 -induced changes in transcriptome signatures were similarly robust in kidney
as compared to the lung, but more modest in spleen. Transcriptomic signatures
in lung and kidney were indicative of infiltration and/or expansion of neutrophils,
macrophages, dendritic cells, B cells, and T cells that corresponded with accelerated
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autoimmune pathogenesis. Taken together, airway exposure to cSiO2 elicited aberrant
mRNA signatures for both innate and adaptive immunity that were consistent with
establishment of the lung as the central autoimmune nexus for launching systemic
autoimmunity and ultimately, kidney injury.
Keywords: autoimmunity, NanoString, lung, systemic lupus erythematosus, silica, transcriptome

INTRODUCTION

responses were similarly reflected in the plasma and, therefore,
indicate concomitant systemic autoimmunity. Collectively, these
observations suggest that ELS in the lung might be central
autoimmune triggering by cSiO2 .
Recently, we characterized ELS development and
autoimmunity over time in NZBWF1 mice that were intranasally
instilled with cSiO2 weekly for 4 weeks and then sacrificed 1, 5,
9, or 13 weeks later (15). By week 1, inflammation comprising
of B and T cells was observed in lungs of cSiO2 -treated mice;
these responses were continually amplified at 5, 9, and 13
weeks. Marked FDC networking appeared at 9 and 13 weeks
PI. IgG+ plasma cells suggestive of mature germinal centers
were evident at 13 weeks. Anti-dsDNA IgG in bronchial lavage
fluid and plasma increased over the course of the experiment.
cSiO2 -induced glomerulonephritis with concomitant B-cell
accumulation in the renal cortex was evident at 13 weeks PI.
Accordingly, cSiO2 sequentially induced ectopic lymphoid
neogenesis, germinal center development, systemic autoantibody
elevation, and resultant glomerulonephritis in this unique
preclinical model of environment-triggered lupus.
Little is known about how acute or chronic cSiO2 exposures
impact global immune gene expression. To address this, we
tested the hypothesis that upregulation of adaptive immune
function genes in the lung precedes cSiO2 -triggering of
autoimmune disease in the NZBWF1 mouse. The NanoString
nCounter platform is a targeted multiplex approach that enables
measurement of up to 800 genes in a single reaction with high
sensitivity and linearity across a broad dynamic range (16–18).
Based on direct digital detection of mRNA molecules utilizing
target-specific, color-coded probe pairs, this method bridges
the gap between RNAseq and targeted RT-PCR expression
profiling. Herein, we employed the nCounter platform to:
(1) relate temporal changes in immune-related transcriptome
signatures in the lung following acute and short-term repeated
intranasal cSiO2 exposure to ELS development and autoimmune
pathogenesis in female NZBWF1 mice and (2) compare the
terminal transcriptome signatures in the lung to those in the
spleen and kidney.

Systemic
lupus
erythematosus
(lupus)
is
a
devastating autoimmune disease (AD) with a multifaceted
etiology and widely variable disease manifestations. The
initiating event in lupus is loss of tolerance to self-antigens which
elicits production of autoreactive antibodies and formation of
circulating immune complexes [reviewed in Pons-Estel et al.
(1)]. These complexes deposit in tissues where they promote
infiltration and activation of circulating mononuclear cells.
Importantly, deposition of these immune complexes in the
kidney results in glomerulonephritis that can advance to
end-stage renal failure—a major cause of death in lupus patients.
Ectopic lymphoid structures (ELS) are hallmarks of AD that
reflect the interface between unresolved inflammation and loss
of self-tolerance. Unlike secondary lymphoid organs, ELS are
induced at sites of unresolved inflammation, and thus, not found
in pre-programmed places of the body. Their de novo formation
facilitates accelerated initiation of an adaptive immune response
by promoting antigen presentation and rapid activation of naïve
B- and T-cells to remediate the offending agent at the site of
inflammation (2–4). When organized within follicular dendritic
cell (FDC) networks, ELS contain functional germinal centers
that yield autoantibody-secreting plasma cells and promote AD.
Lupus and other ADs are strongly associated with an
individual’s genome. However, low concordance rates among
monozygotic twins indicate that heredity is not the sole disease
determinant (5). Recent studies suggest that the exposome (i.e.,
cumulative lifetime environmental exposures) is an understudied
contributor to AD heterogeneity (6). Crystalline silica (cSiO2 )
is a widely recognized environmental trigger of autoimmunity.
Over 2.3 million Americans are employed in occupations with
high potential exposure to airborne cSiO2 particles, such as
construction, stone cutting, foundries, and hydraulic fracturing
(7). Epidemiological studies have established an etiological link
between occupational exposure to cSiO2 and ADs, including
lupus, rheumatoid arthritis, Sjögren’s syndrome, scleroderma,
and systemic vasculitis (8–12).
In lupus-prone female NZBWF1 mice, intranasal cSiO2
instillation triggered autoimmunity and glomerulonephritis 3
months earlier than vehicle-instilled controls (13, 14). Extensive
inflammatory perivascular and peribronchial leukocyte infiltrates
were evident in the lungs that contained numerous B cells
and T cells corresponding to ectopic lymphoid neogenesis.
Concomitant with pulmonary inflammation and ELS formation,
bronchoalveolar lavage fluid (BALF) from cSiO2 -exposed mice
contained large numbers of neutrophils and macrophages as
well as elevated concentrations of IgG, autoantibodies, IL-1β,
IL-6, TNF-α, and B cell activating factor (BAFF). The latter
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MATERIALS AND METHODS
Animals and Diets
Experimental protocols were approved by the Institutional
Animal Care and Use Committee at Michigan State University
in accordance with the National Institutes of Health guidelines
(AUF #01/15-021-00). Female 6-week-old lupus-prone NZBWF1
mice were provided by Jackson Laboratories (Bar Harbor, ME)
and randomized into experimental groups. Mice were housed
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four per cage and fed AIN-93G diet (Dyets Inc., Bethlehem, PA)
as described previously (13, 15). Mice had free access to food
and water and were kept at constant temperature (21–24◦ C) and
humidity (40–55%) under a 12/h light/dark cycle.

on acute and chronic changes in immune gene expression. This
method was selected over other targeted multiplex approaches
because it (i) requires minimal sample preparation, (ii) does
not require cDNA conversion or target amplification—both
major sources of variation in conventional qRT-PCR approaches,
(iii) has robust user software for gene analysis, and (iv) has
been repeatedly demonstrated to correlate well other microarray
platforms (19–21). Briefly, RNA (n =7–8/gp) was analyzed
using the nCounter Mouse PanCancer Immune Profiling Panel
(catalog # 115000142), which includes 770 immune-related
genes, 40 housekeeping genes, and 6 positive controls. Assays
were performed and quantified on the nCounter MAX system,
sample preparation station, and digital analyzer (NanoString
Technologies) according to the manufacturer’s instructions.
Briefly, reporter and capture probes were hybridized to target
analytes for 16 h at 65◦ C. After hybridization, samples were
washed to remove excess probes. Then, the purified target-probe
complexes were aligned and immobilized onto the nCounter
cartridge, and the transcripts were counted via detection of
the fluorescent barcodes within the reporter probe. Probe
annotations are provided in Supplementary File 1.
Raw gene expression data were analyzed using NanoString’s
software nSolver v3.0.22 with the Advanced Analysis
Module v2.0. Background subtraction was performed
using the eight included negative controls included with
the module. Genes with counts below a threshold of
2σ of the mean background signal were excluded from
subsequent analysis (Supplementary Figures 1–3). Data
normalization was performed on background-subtracted
samples using internal positive controls and selected
housekeeping genes that were identified with the geNorm
algorithm (https://genorm.cmgg.be/).
Ratios of transcript count data were generated for cSiO2 treated mice vs. VEH control as follows: acute response in
lung tissue of cSiO2 -treated (single dose) mice vs. dosingmatched vehicle controls 1 day post instillation (Acute.1x);
acute response in lung tissue of cSiO2 -treated (four weekly
doses) mice vs. dosing-matched control 1 day post instillation
(Acute.4x); chronic response in lung tissue of cSiO2 -treated
(four weekly doses) mice vs. dosing- and time-matched vehicle
controls 1, 5, 9, or 13 weeks post instillation (Lung.W1,
Lung.W5, Lung.W9, Lung.W13, respectively); chronic
response in kidney tissue of cSiO2 -treated (four weekly
doses) mice vs. dosing- and time-matched vehicle controls
13 weeks post instillation (Kidney.W13); chronic response
in spleen tissue of cSiO2 -treated (four weekly doses) mice
vs. dosing- and time-matched vehicle controls 13 weeks post
instillation (Spleen.W13). Ratios were then log2 transformed for
downstream analysis.

cSiO2
cSiO2 (Min-U-Sil-5, 1.5–2.0 µm average particle size,
Pennsylvania Sand Glass Corporation, Pittsburgh, PA) was
acid washed and dried before addition of sterile phosphate
buffered saline (PBS). Stock suspensions were prepared fresh in
PBS prior to exposure and suspensions sonicated and vortexed
for 1 min before intranasal instillation.

Experimental Design
Figure 1 depicts the experimental design for this study. To model
acute response to a single dose of cSiO2 , (Acute.1x) groups of
8-week-old mice (n = 8/gp) were anesthetized with 4% isoflurane
and intranasally instilled with 1.0 mg cSiO2 in 25 µl PBS or 25
µl PBS vehicle (VEH) as described previously (13). To capture
the acute response to short-term repeated exposure to cSiO2 , a
second cohort of mice received 1.0 mg cSiO2 or VEH once weekly
for 4 weeks (Acute.4x). Each cohort was sacrificed 24 h after final
instillation. The caudal lung lobe was removed, held in RNAlater
(Thermo Fisher Scientific, Wilmington, DE) overnight at 4◦ C,
and then stored at −80◦ C for RNA multiplexing.
To visualize how cSiO2 impacts autoimmune gene expression
over the long term, we used tissues from our recently published
investigation that focused on the histopathological changes
over time in cSiO2 -treated NZBWF1 mice (15). In that study,
beginning at 8 weeks of age, groups of mice on were exposed
to VEH or cSiO2 weekly for 4 weeks. Thereafter, cohorts of
mice were sacrificed over time at 1, 5, 9, and 13 weeks post
final cSiO2 exposure. One mouse in the 5 week VEH group
died of unknown causes during the course of the experiment;
it did not show the typical signs of sickness including loss of
body weight before death. Tissues were collected at stored in
RNAlater (ThermoFisher Scientific). Lungs were analyzed at 1
(Lung.W1), 5 (Lung.W5), 9 (Lung.W9), and 13 (Lung.W13)
weeks post cSiO2 exposure, and spleen (Spleen.W13) and kidney
(Kidney.W13) at 13 weeks. These time points were selected to
coincide with pathological changes previously described in this
model following cSiO2 exposure prior to and during onset of
glomerulonephritis (13–15).

Gene Expression Analysis With NanoString
nCounter
Total RNA was extracted from lung, spleen, and kidney with
TriReagent (Sigma Aldrich, St. Louis, MO) per manufacturer’s
instructions. Resultant RNA was further purified and genomic
DNA removed by RNeasy Mini Kit with DNase treatment
(Qiagen, Valencia, CA). RNA was dissolved in nuclease-free
water and quantified using a NanoDrop-1000 (Thermo Fisher).
Samples were then analyzed for RNA integrity using a LabChip
Gx Analyzer (Caliper Life Sciences, Waltham, MA). Samples with
RIN values >7.0 were included for gene expression analysis.
The NanoString nCounter (NanoString Technologies, Inc.,
Seattle WA) was used to assess the effects of cSiO2 exposure

Frontiers in Immunology | www.frontiersin.org

Data Analysis
Differential gene expression analyses were performed using
nSolver, which employs several multivariate linear regression
models to identify significant genes (mixture negative binomial,
simplified negative binomial, or log-linear model) as outlined
in Supplementary Figure 4. Resulting p values were adjusted
using the Benjamini-Hochberg (BH) method to control the false
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FIGURE 1 | Design of experiments. At 8 weeks of age, female NZBWF1 mice were dosed intranasally with 25 µl PBS (VEH) or 25 µl PBS containing 1.0 mg cSiO2
once (A; experiment 1) or weekly for 4 weeks (B,C; experiments 2 and 3). Cohorts (n = 7–8) of mice were euthanized and necropsied 1 day (experiment 1 and 2)
following the only/final instillation or 12, 16, 20, or 24 weeks of age corresponding to 1, 5, 9, or 13 weeks post the final instillation (experiment 3). Tissues obtained for
nCounter digital transcript counting (NanoString PanCancer Immune Profiling gene set) are indicated above.

discovery rate. Statistically significant, differentially expressed
genes were defined as those with expression levels corresponding
to a log2 ratio >1 or <−1 and BH q value <0.05 for cSiO2
treatments compared to the appropriate vehicle control group
(Supplementary Figure 5). Outputs from nSolver differential
expression analysis are provided in Supplementary File 2. Venn
diagrams of significant differentially expressed genes in cSiO2
groups were generated using BioVenn (22) or Venny v2.1 (23).
To assess impact of cSiO2 treatment on annotated gene
sets, global and directed significance scores were calculated
for each pathway. The global significance score for each gene
set was calculated as the square root of the mean squared
t-statistic of genes, as determined by the differential gene
expression analyses. The global score estimates the cumulative
evidence for the differential expression of genes in a pathway.
A directed significance score was also calculated by taking
into account the sign of the t-statistics. Directed significance
scores near zero may have many highly regulated genes, but
Frontiers in Immunology | www.frontiersin.org

no apparent tendency for those genes to be over- or underexpressed collectively. Pathway scores were used to summarize
data from a pathway’s genes into a single score. Pathway
scores were calculated as the first principal component of the
pathway genes’ normalized expression and standardized by
Z scaling. ClustVis (24) was used to perform unsupervised
hierarchical cluster analyses (HCC) and principal components
analyses (PCA) using log2 transcript count data. Supplementary
Files 3–4 provide summary tables for all significance and
pathway Z scores.

Immune Cell Profiling
A significant discovery feature of the NanoString platform is
cell profiling, which uses marker genes expressed stably and
specifically in immune cell types to estimate relative abundance
in sample groups measured as the average log-scale expression
of their characteristic genes (25). Note that this analysis does not
provide information on the absolute number of immune cells in
4
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profiles distinguished the immediate immune response to a
single exposure of cSiO2 as compared to that after repeated
cSiO2 exposures.
Hierarchical clustering of the 56 genes differentially expressed
in either exposure regimen revealed that the changes were more
pronounced following four exposures to cSiO2 than those elicited
by a single exposure to cSiO2 (Figure 2C). In general, these
changes were associated with increased expression as relatively
few genes were repressed. Clustering analysis also indicated
that three out of eight mice exposed only once to cSiO2 were
strong responders whose transcriptomes mirrored the more
severe responses observed all eight mice following four repeated
cSiO2 exposures.
To identify which immunological pathways were significantly
altered and were upregulated or enhanced by cSiO2 exposure,
global and directed significance scores, respectively, were
calculated as described above (Figure 2D). The resultant
significance scores show broad scale activation of immune
pathways. As indicated in heat maps of global and directed
significance scores, the involvement of several immune pathways
began after a single dose of cSiO2 and was amplified
upon repeated exposures. Importantly, the vast majority of
immune pathways had potentiated expression, as opposed to
attenuation, following a single or multiple exposures to cSiO2 .
Network analyses of differentially expressed genes in lungs
of mice with multiple cSiO2 exposures revealed transcript
groupings broadly associated with interferon (IFN) signaling,
chemokine and cytokines, innate and adaptive immune response
(Supplementary Figure 6).
To ascertain how different exposures to cSiO2 influenced
the overall gene expression, Z scores were calculated using
expression values from all genes assigned a given pathway for
each mouse in a treatment group, and the data were expressed
as heat maps (Figure 3A). Again, strong responders in mice
treated with one dose of cSiO2 clustered closely and markedly
reflected the gene response of mice instilled with multiple doses
of cSiO2 . Importantly, immune pathways consistently activated
in cSiO2 -treated mice were largely parallel with pathways known
to influence the development of autoimmunity; these responses
were absent in mice treated with vehicle alone (Figure 3B).
Based on previous studies by our group (15), we chose to
elaborate on gene expression profiles with heat maps of the innate
immune pathway (Figure 4A), the adaptive immune pathway
(Figure 4B), B-cell functions (Figure 4C), T-cell functions
(Figure 4D), chemokines and receptors (Figure 4E), cytokines
and receptors (Figure 4F), and interferon (Figure 4G). When
expression of representative genes of each of these pathways
were plotted (Figure 4, dot plots to right of each heat map),
upregulation of a number of genes in Acute.4x group were
consistent with the Acute.1x high responders. Among the
overlapping genes were the chemokines Cxcl1, Cxcl5, Ccl2,
Ccl3, and Ccl7 suggesting that leukocyte recruitment was a
critical primary response 1 d after cSiO2 instillation. Expression
of these genes were considerably ramped up after short-term
repeated exposure to the particle. Interestingly, a number of
genes associated with netosis (26) were also upregulated by
cSiO2 including C3ar, Ccl2, Ccl3, Cd14, Cd83, Cxcl, Ifit3, Il1a,

a sample. Cell types and genes compatible with the PanCancer
Immune Profiling Panel included leukocytes (Ptprc), B cells
(Ms4a1, Tnfrsf17), T cells (Cd3d, Cd3e, Cd3g, Cd6, Sh2d1a),
Th1 cells (Tbx21), T reg (Foxp3), CD8 T cells (Cd8a, Cd8b1),
exhausted CD8 cells (Cd244, Eomes, Lag3), cytotoxic cells (Ctsw,
Gzma, Gzmb, Klrb1, Klrd1, Klrk1, Prf1), dendritic cells (Ccl2,
Cd209e, Hsd11b1), macrophages (Cd163, Cd68, Cd84), mast
cells (Ms4a2), neutrophils (Csf3r, Fcgr4), and NK cells (Ncr1,
Xcl1). The nCounter Advanced Analysis module reports p value
confidence thresholds for reporting for cell types with multiple
markers, though gene sets with high p-values may be useful if
use of the biomarker genes is supported by prior studies. For
this study, we report results for the immune cell types listed
above, including those with threshold p values >0.05 as those
data may be useful in future exploratory work. Supplementary
File 5 provides the log2 scores for cell type profiling.

Network Analysis
Network analyses for interactions among significant genes were
performed using STRING database version 10.5 (http://stringdb.org/), which curates both experimental and predicted gene
interactions. Only interactions among significant genes identified
by the nSolver data analysis were considered with the confidence
level for associations set at ≥0.7. Clusters were identified
using the Markov Cluster (MCL) algorithm with inflation
parameter of 1.5. Networks generated by STRING were visualized
with Cytoscape v3.0, with nodes representing significant genes
and edge width indicating the combined interaction score.
Supplementary File 6 provides data for STRING-db networks and
the predicted clusters.

Correlation Analysis
Spearman rank correlations were performed to examine
overall patterns in the gene expression profiles compared
to histopathological lesions in lung tissues and markers of
immune cells. Correlation analysis was performed using cor
and corrplot functions in R (www.R-project.org). Spearman ρ
values were calculated using individual sample pathway Z scores
and phenotype data: histopathology scores (lymphoid aggregates,
ectopic lymphoid structures, alveolar proteinosis, alveolitis, type
2 cell hyperplasia, and mucus cell metaplasia) or percent positive
staining (CD3, CD45R, and CD21/35) for lung tissues obtained
from mice at 1, 5, 9, and 13 weeks post instillation (15). A
significant correlation was inferred when ρ > 0.5 or <−0.5
and p < 0.05.

RESULTS
Acute mRNA Responses Following Single
and Short Term cSiO2 Exposure Indicate
Innate and Adaptive Immune Activation
Five genes were differentially expressed in lung tissue 24 h after
a single intranasal instillation of cSiO2 (Acute.1x) whereas 56
genes were upregulated 24 h after four weekly cSiO2 installations
(Acute.4x) (p < 0.05) (Figure 2A, see Supplementary Tables 1,
2 for a full list of genes). Principal component analysis
(PCA) plots (Figure 2B) indicated that distinct gene expression
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FIGURE 2 | Acute transcriptional response of immune-associated genes in lung tissues of mice that received either a single or four weekly instillations of cSiO2 . Mice
received a single dose (Acute.1x) or four repeated weekly doses (Acute.4x) of cSiO2 via intranasal instillation, and gene expression was determined in lung tissues
obtained 1 day after the last dose. (A) Venn diagram depicting the number of genes identified as differentially expressed in lung tissue of mice that received a single
cSiO2 instillation (orange line) or four weekly cSiO2 doses (blue dashed line) as compared to dosing-matched vehicle controls. (B) Principal components analysis of
differentially expressed genes (BH q < 0.05, log2 ratio >1 or <−1) in lung tissues of mice exposed to cSiO2 once or four times compared to dosing-matched vehicle
controls. PC1 and PC2 are shown with the 95% confidence interval bands (dashed ellipses). (C) Unsupervised, bidirectional hierarchical cluster analysis of lung
immune pathway transcriptome data using the Euclidean distance method with average linkage. All genes differentially expressed in either the Acute.1x (orange) or
Acute.4x (blue) treatment groups were included in the heatmap, which is colored by the log2 ratio of transcript counts calculated with respect to average expression in
dosing-matched vehicle controls. (D) Heatmaps depicting either global or directed significance scores for immune-related pathways (see Materials and Methods for
details on calculation of significance scores).

expressed genes in the lung increased over time: 77 genes at
1 week, 92 genes at 5 weeks, 110 genes at 9 weeks, and 108
genes at 13 weeks (Figure 6B); again, most of these genes were
upregulated with a few repressed (Supplementary Tables 3–6).
PCA plots (Figure 6C) and hierarchical clustering heat maps
(Figure 6D) revealed some variance in gene expression profiles
over time as evidenced by less distinct clustering by time
point, with most variance in individual mice observed at 9
and 13 weeks post exposure. Also, though a core set of 39
genes were commonly differentially regulated by cSiO2 at all
time points (Figure 6B), both PCA and HCC analyses suggest
a shift in overall gene expression profiles over time such that
the lung transcriptome during early disease was distinct from
that at later disease stages. Global and directed significance
scores highlight the dramatic involvement of several immune
pathways that appear to be well-established by 5 weeks post final
exposure to cSiO2 (Figure 6E). Corresponding to 16 weeks of
age, this time point may represent a critical transitional step
for the establishment of diverse networks of immune pathways.
Network visualization of differentially expressed genes in lungs
over the course of disease development aligns well with the
NanoString pathway analyses, as the resulting networks showed
clear groupings of transcripts associated with innate and adaptive
immunity, chemokine, cytokines interferon, and complement
(Supplementary Figures 7–10).
Immune pathways in the lungs of individual mice treated
with either cSiO2 or VEH clearly segregated into distinct

Irf7, and Slc11a1 (Figure 4) as well as Mmp9 and Rsad2
(Supplementary Table 2).
Using marker genes expressed stably and specifically in
immune cell types, we estimated relative abundance in sample
groups measured as the average log-scale expression of their
characteristic genes. Congruent with chemokine effects, several
immune cell populations were changed in lung tissue of mice
following a single or multiple exposures to cSiO2 (Figure 5).
Notably, leukocytes, neutrophils, and T-cells were significantly
increased following a single exposure to cSiO2 , indicating a rapid
immune response with recruitment of circulating lymphocytes.
After multiple exposures, mRNA signatures were suggestive of
elevations in cells associated with the innate (macrophages,
neutrophils, NK cells) and adaptive immune responses (dendritic
cells, B cells, and various classes of T-cells including exhausted
CD8 T-cells and Treg cells). Overall, the acute response
data following single and short-term repeated exposures were
suggestive of a nascent autoimmune response.

Short-Term Repeated cSiO2 Exposure
Induces Chronic Changes in Lung mRNA
Signatures Consistent With a Vigorous
Autoimmune Response
Many of the same genes that were induced in the lung 24 h after
the fourth installation of cSiO2 were also induced 1 week after
the fourth exposure (Figure 6A). The number of differentially

Frontiers in Immunology | www.frontiersin.org

6

March 2019 | Volume 10 | Article 632

Bates et al.

Silica-Triggered Transcriptome Changes

FIGURE 3 | Lung tissue gene expression pathway Z scores for mice that received either a single or four weekly instillations of cSiO2 . (A) Heatmap depicts individual
pathway Z scores of each immune pathway for lung tissues obtained from vehicle (VEH) or cSiO2 -treated mice following a single (Acute.1x) or four weekly (Acute.4x)
instillations. (B) Pathway Z scores are presented as Tukey box-plots (n = 8) for select immune pathways of interest. **p < 0.01; ***p < 0.001, and ****p < 0.0001
compared to dosing-matched vehicle control as determined by the non-parametric Wilcoxon test.

interferon, complement pathway, and TNF superfamily) whereas
other pathways were modestly induced at early time points
but markedly increased with progression of cSiO2 -induced

clusters at each time point (Figure 7A). Notably, some pathways
were responsive early on and then maintained consistent
expression throughout the course of AD development (e.g.,
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FIGURE 4 | Comparison of significant differentially expressed genes associated with immune response in lung tissues of mice that received either a single or four
weekly instillations of cSiO2 . Gene expression data for (A) innate, (B) adaptive, (C) B-cell functions, (D) T-cell functions, (E) chemokines & receptors, (F) cytokines &
receptors, and (G) interferon pathways were calculated as the log2 ratio of cSiO2 with respect to dosing-matched vehicle (VEH) controls for mice that received a
single (Acute.1x) or four weekly (Acute.4x) cSiO2 instillations. For each pathway of interest, a heatmap with unsupervised clustering (Euclidian distance method) by
gene is shown for all genes identified as significantly differentially expressed (BH q < 0.05, log2 ratio >1 or <−1) for either dosing protocol. Additionally, the mean log2
ratio values ± SEM for selected genes of interest are also shown for each panel. Note that some genes are associated with multiple immune response pathways, and
thus, these genes appear in multiple panels.

software (Figure 9). Consistent with differential counts of
bronchiolar lavage fluid carried out in the parent study (15),
both macrophages and neutrophils increased in lungs of
cSiO2 -exposed mice over time. Also, in accordance with our
prior finding that cSiO2 induced pulmonary ectopic lymphoid
neogenesis, B-cell, T-cell, and dendritic cell mRNA signatures
were increased in lungs of cSiO2 -treated mice. Intriguingly, Treg
cells and exhausted CD8 T-cells were also increased in cSiO2 treated mice.
Most pathways in individual lungs of cSiO2 -exposed lupusprone mice correlated with pathological features the same lung
tissues reported in the parent study (15) in a time-dependent
manner (Figure 10). Again, the time between weeks 5 and 9 was
particularly a critical period for transition.

autoimmunity (e.g., adaptive immunity, B-cell functions and
T-cell functions) (Figure 7B).
Differentially expressed genes identified in immune pathways
likely to be involved in the pathogenesis of cSiO2 -triggered
autoimmunity are depicted in heat maps (Figure 8). Expression
levels for selected genes representing these immunological
pathways are also shown as line plots as a function of time to
the right of these heat maps. Consistent with immune pathways,
at least three trends were evident for these individual genes.
Some genes were upregulated at 1 week post exposure and
continued to increase over time (e.g., Ccl2, Cxcl10, Cxcl13, Cxcl5).
Other sets of genes were modestly elevated at week 1 post
exposure and remained so over the course of the experiment
(e.g., Marco, Cfb, Ctla4, Spp1). Lastly, expression of a small
number of genes (e.g., Camp, Hamp, Txk, Cfd, and Il11ra1)
decreased over the length of the study. In addition, sequential
comparisons over time were made to identify changes in gene
expression as the disease progresses in the cSiO2 -exposed mice
(Supplementary Figure 11). Upon comparing week 5 vs. week 1,
week 9 vs. week 5, or week 13 vs. week 9, significant differences
in relative expression >2-fold were identified for 17, 12, or 5
genes, respectively.
Immune cell type profiling in the lung based on expression
of cell-specific mRNAs was carried out using NanoString

Frontiers in Immunology | www.frontiersin.org

Some, but Not All, cSiO2 -Induced mRNA
Signatures in Lung Correlate With Those in
Spleen and Kidney
To learn how the transcriptional responses in the lungs related
to other organs associated with the autoimmunity, we compared
lung mRNA signatures at 13 weeks after the final instillation of
cSiO2 to those in the spleen and kidney at the same time point. In
spleen, 32 genes were altered and, strikingly, 168 were altered in
the kidney (Figure 11A). Importantly, 55 genes were expressed
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FIGURE 5 | Profiling of immune cell types in lung tissues obtained from mice that received either a single or four weekly instillations of cSiO2 compared to
non-exposed counterparts. Data shown are the log2 cell type scores for mice for mice that received a single (Acute.1x) or four weekly (Acute.4x) instillations of cSiO2
or saline vehicle (VEH). Scores may be compared within a cell type by dosing frequency to infer differences in abundance, but comparisons across cell types are not
appropriate for this method of quantitation. *p < 0.05; **p < 0.01; and ***p < 0.001 compared to dosing-matched vehicle control as determined by the
non-parametric Wilcoxon test.

reveal paralleled expression of a pathway within tissues of a
given animal (Figure 12A). Like the lung, responses within the
kidney were quite dramatic, whereas the involvement of the
same pathways in the spleen were more modest. Despite the
comparatively mild influence of cSiO2 on the spleen, pathway
scores were significantly increased in the spleen, as well as the
lung and kidney, relative to VEH-treated mice (Figure 12B). A
similar pattern was evident for the two network visualizations
of differentially expressed transcripts in kidney and spleen.
For kidney, the network was highly interconnected with major
groupings of genes associated with interferon, chemokines and
cytokines, TNF signaling, MHC molecules, adhesion, and CD
molecules (Supplementary Figure 12). In contrast, the network
for cSiO2 -responsive transcripts in spleen tissues was primarily
limited to chemokines and cytokines, with small clusters of
three genes associated with interferon or basic cell functions
(Supplementary Figure 13).

both in the lung and kidney, and 11 genes were common to all
tissues at 13 weeks post final exposure (Supplementary Tables 7,
8). PCA indicated the expression profile of the lung clearly
segregated from the kidney and spleen, although gene expression
profiles for spleen and kidney could not be differentiated by
the first two principal components (Figure 11B). Hierarchical
clustering clearly demonstrated a substantial immune response
in the kidney occurring as a result of intranasal cSiO2 exposure,
which paralleled closely with genes expressed in the lung and
to a lesser extent, the spleen (Figure 11C). Significance scores
in the kidney and spleen highlight that, as expected, the lung
is the central affected organ at this time point (Figure 11D).
However, all tissues have increased involvement of numerous
immune pathways, with the kidney having a stronger response
than the spleen at 13 weeks post final instillation of cSiO2 .
Further analysis of the immune pathways affected by
intranasal cSiO2 exposure in the spleen and kidney at 13 weeks
Frontiers in Immunology | www.frontiersin.org
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FIGURE 6 | Chronic transcriptional response of immune-associated genes in lung tissues of mice 1, 5, 9, or 13 weeks post cSiO2 instillation. Mice received four
repeated weekly doses of cSiO2 or saline vehicle (VEH) via intranasal instillation, and gene expression was determined in lung tissues obtained 1, 5, 9, or 13 weeks
post instillation. (A) Venn diagram depicting the number of genes identified as differentially expressed in lung tissue of mice 1 day (Acute.4x) or 1 week (Lung.W1) post
cSiO2 instillation compared to dosing-matched vehicle controls. (B) Venn diagram depicting the number of genes identified as differentially expressed in lung tissues
over time as compared to time-matched, vehicle-exposed mice. (C) Principal components analysis of differentially expressed genes (BH q < 0.05, log2 ratio >1 or
<−1) in lung tissues of mice exposed to cSiO2 at 1, 5, 9, or 13 weeks post instillation compared to time-matched vehicle controls. PC1 and PC2 are shown with 95%
confidence interval bands (dashed ellipses). (D) Unsupervised, bidirectional hierarchical cluster analysis of lung transcriptome data at weeks 1, 5, 9, or 13 using the
Euclidean distance method with average linkage. All genes differentially expressed at any of the time points were included in the heatmap, which is colored by the log2
ratio calculated with respect to average expression in time-matched vehicle controls. (E) Heatmaps depicting either global or directed significance scores for
immune-related pathways (see Materials and Methods for details on calculation of significance scores).

in the lungs following cSiO2 exposure. The latter correlates
with glomerulosclerosis.
Immune cell profiling indicated the involvement of cells of
the innate and adaptive immune system in the transcriptional
response of the spleen and kidney (Figure 14). As observed in
the lung, leukocytes, dendritic cells, macrophages, neutrophils,
and exhausted CD8 T-cells had statistically significant increased
abundance in the spleen and kidney at 13 weeks post instillation.

Figure 13 depicts selected tissue-specific gene responses
within each immune signaling pathway. It is notable that
a large number of genes associated with innate and T
cell function were upregulated only in the kidney, such as
Tlr8, Ccl5, and Cxcr6 (Figure 13A) or Itgal, Ccr2, and Cd48
(Figure 13D), respectively. In addition, two additional families
of mRNA transcripts related to adhesion molecules and collagen
deposition were present in the kidneys but not identified
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FIGURE 7 | Lung tissue gene expression pathway Z scores at 1, 5, 9, or 13 weeks post cSiO2 instillation. (A) Heatmap depicts individual pathway Z scores of each
immune pathway for lung tissues obtained from mice 1, 5, 9, or 13 weeks post instillation with cSiO2 (four weekly doses) or time-matched vehicle (VEH) controls.
(B) Pathway Z scores are presented as Tukey box-plots (n = 7–8) for select immune pathways of interest. **p < 0.01; and ***p < 0.001 compared to time-matched
vehicle control as determined by the non-parametric Wilcoxon test.

urate, cholesterol) (27). Targeted multiplex gene expression
analysis with the nCounter provided a focused strategy to
test the hypothesis that upregulation of adaptive immune
function genes in the lung precedes cSiO2 -triggering in the
NZBWF1 mouse. We found that cSiO2 indeed induced wide
scale adaptive immune gene upregulation and furthermore,
these responses were intricately linked the particle’s capacity
to elicit an early and persistent inflammatory stimulus in
the lung that promoted expression of mRNAs indicative both
innate and adaptive immune pathways. Several novel findings
were made in this investigation. First, relevant to lupus,
dramatic increases were observed in mRNAs associated with
chemokine release, cytokine production, sustained IFN activity,

Additionally, like the lung, T-cells were increased in the
kidney. The spleen had fewer cell types that achieved statistical
significance possibly due to this tissue having higher basal
expression of these markers which masked subtler effects of cSiO2
in this tissue.

DISCUSSION
Identifying the critical genes associated with cSiO2 -triggered
autoimmunity is of great importance because this particle has
been linked to human AD. Furthermore, this response may
model those of other exogenous particles (e.g., asbestos, carbon
nanotubes) as well as endogenous particles (e.g., monosodium
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FIGURE 8 | Time course of significant differentially expressed genes associated with immune response in lung tissues of mice 1, 5, 9, or 13 weeks post instillation
with cSiO2 . Gene expression data for (A) innate, (B) adaptive, (C) B-cell functions, (D) T-cell functions, (E) chemokines & receptors, (F) cytokines & receptors, and (G)
interferon pathways were calculated as the log2 ratio of expression values for cSiO2 -treated mice at 1, 5, 9, or 13 weeks PI with respect to time-matched vehicle
controls. For each pathway of interest, a heatmap with unsupervised clustering (Euclidian distance method) by gene is shown for all genes identified as significantly
differentially expressed (BH q < 0.05, log2 ratio >1 or <−1) at any one of the indicated time points. The mean log2 ratio values ± SEM for selected genes of interest
are also shown for each panel. Note that some genes are associated with multiple immune response pathways, and thus, these genes appear in multiple panels.

cSiO2 (i.e., Acute.1x) were variable with three out of eight
mice being extremely high responders and the remainder
being low responders. Remarkably, signatures among these high
responders were highly consistent with the less variable responses
observed 24 h after short term repeated dosing (Acute.4x group).
Variability in the single dose acute study might be attributable
to use of intranasal instillation as the delivery route for cSiO2 .
Particle suspensions deposited at the anterior nares can distribute
into three sites in the mouse: (i) the upper respiratory tract,
(ii) the lower respiratory tract, and (iii) the digestive system
(28). Thus, variability might have resulted from slow and/or
incomplete dissemination of the cSiO2 particles in the lower
airways of some mice at 1 d following a single dose (29).
Comparatively, cSiO2 dissemination might be more uniform
after four dosages and longer time period than was achieved 24 h
after a single installation.

complement activation, and adhesion molecule expression.
Second, consistent with previously described histopathologic
stages of cSiO2 -triggered autoimmune pathogenesis (15), the
time between 5 and 9 weeks PI was an important transition
period for gene upregulation in the lung. Third, at experiment
termination, cSiO2 -induced changes in transcriptome signatures
were equally robust in kidney but more modest in spleen.
Finally, transcriptomic signatures in lung and kidney were
indicative of expansion and/or activation of several leukocyte
populations including neutrophils, macrophages, dendritic cells,
B cells, and T cells that corresponded with accelerated
autoimmune pathogenesis.
Both single and multiple cSiO2 exposure protocols were
employed here to map time-dependent changes in transcriptome
signatures in the lung following cSiO2 exposure. Regarding
acute responses, mRNA signatures 24 h after a single dose of
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FIGURE 9 | Profiling of selected immune cell types in lung tissues at 1, 5, 9, or 13 weeks post cSiO2 instillation. Data shown are the log2 cell type scores for lung
tissues obtained 1, 5, 9, or 13 weeks following four weekly instillations with cSiO2 or saline vehicle (VEH). Scores may be compared within a cell type at each time
point to infer differences in abundance, but comparisons across cell types are not appropriate for this method of quantitation. *p < 0.05; **p < 0.01; ***p < 0.001
compared to time-matched vehicle control as determined by the non-parametric Wilcoxon test.

observed in the kidney are more likely driven by autoantibodies
arising in the lung. These autoantibodies likely enter into the
systemic compartment in the unbound form or as immune
complexes with autoantigens and subsequently deposit in distal
tissues—most notably kidney. There they could elicit robust
inflammatory responses resulting in glomerulonephritis. Thus,
the transcriptome signatures observed in the kidney most likely
reflect downstream effects of the ectopic lymphoid neogenesis in
the lung.
Diverse chemokine genes were consistently upregulated in
lung at all time points following cSiO2 exposure. Chemokines
are released from injured cells to recruit resident and circulating
leukocytes to sites of inflammation by way of concentration
gradients. Both C-X-C and C-C chemokines were identified in
lung, kidney, and to a lesser extent spleen, thus implicating
neutrophils, macrophages, B-cells, and T-cells in the progression

Relative to short-term repeated exposures to cSiO2 ,
transcriptome signatures in the lung broadly reflected both
activation of innate and adaptive pathways. While similar genes
associated with disease pathways were significantly upregulated
1 d and 1, 5, 9, and 13 weeks after the final cSiO2 instillation,
both the numbers of genes and response intensity progressively
increased. Notably, PCA analysis indicated that the most critical
breakpoint in expression existed between weeks 5 and 9. This
breakpoint corresponded to a massive expansion of ELS and
appearance of follicular dendritic and plasma cells in the lung
observed immunohistochemically at week 9 in the parent study,
the source of the samples used here for the chronic study (15).
Once cSiO2 enters the lung, it is largely retained at this
site with miniscule amounts translocating to the mediastinal
lymph node and thymus (30, 31). Thus, rather than being
a direct effect of the particle, cSiO2 -driven gene responses
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FIGURE 10 | Correlation analyses of immune-associated pathways and phenotypic endpoints assessed in lung tissues of mice collected 1, 5, 9, or 13 weeks post
instillation with cSiO2 . Spearman ρ values were calculated using pathway Z scores and phenotype data (histopathology scores (lymphoid aggregates, ectopic
lymphoid tissue, alveolar proteinosis, alveolitis, type 2 cell hyperplasia, and mucus cell metaplasia) or percent positive staining tissue (CD3, CD45R, and CD21/35).
Significant correlation values (p < 0.05) are represented as circles colored by the correlation value (blue, positive; red, negative); non-significant correlations are
indicated by blank cells.

Ccl7, Ccl8, and Ccl12 which code for monocyte chemoattractant
protein 1 (MCP-1), MCP-2, MCP-3, and MCP-5, respectively.
In prior work, we have reported that cSiO2 exposure promotes
MCP-1 elevation in BALF and plasma (13). Importantly,
increased MCP-1 in plasma is associated with increased disease
severity in lupus patients (36, 37).
C-X-C motif chemokines that are chemoattractant for B and
T cells were also found to be persistently upregulated by cSiO2 in
lung, spleen, and kidney. Of particular interest here, Cxcl13 was
highly expressed in the lung and kidneys of cSiO2 -treated mice.
This chemokine, also known as B-lymphocyte chemoattractant
(BLC), is preferentially produced by FDCs in B-cell follicles of
lymphoid organs (38) and to some extent, by T follicular helper
cells (39, 40) and Th17 cells (41). Relatedly, experimental antiCXCL13 antibodies have shown promising results on murine
models of autoimmune disease (42).

of cSiO2 -triggered autoimmunity. These findings were highly
consistent with immune cell profiles both identified using
NanoString (Figures 5, 9, 14) and by differential staining of BALF
and immunohistochemistry in the parent study (15). Cxcl5 and
Cxcl3 were consistently among the most highly upregulated genes
following cSiO2 treatment. These chemokines predominately
recruit neutrophils to sites of inflammation via the receptor
Cxcr2. Degranulation of recruited neutrophils may release
proteolytic enzymes into the extracellular space, thus resulting in
bystander tissue injury and promoting lung inflammation (32–
34). In addition, neutrophils at sites of inflammation can die by
NETosis, a form of regulated cell death that releases neutrophil
extracellular traps (NETs) consisting of nuclear material (e.g.,
dsDNA) that could be a source of autoantigen (35).
Other chemokines identified in this study were consistent with
monocyte recruitment into inflamed tissues. These include Ccl2,
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FIGURE 11 | Comparison of chronic transcriptional response of immune-associated genes in lung, kidney and spleen tissues of mice 13 weeks post instillation with
cSiO2. Mice received four repeated weekly doses of cSiO2 or saline vehicle (VEH) via intranasal instillation, and gene expression was determined in lung, kidney and
spleen tissues obtained 13 weeks post instillation. (A) Venn diagram depicting the number of genes identified as differentially expressed in lung, kidney, and spleen
tissues 13 days post installation as compared to time-matched, vehicle-exposed mice. (B) Principal components analysis of differentially expressed genes (BH q <
0.05, log2 ratio >1 or <−1) in lung, kidney, and spleen tissues of cSiO2 -exposed mice compared to time-matched vehicle controls. PC1 and PC2 are shown with
95% confidence intervals (dashed ellipses). (C) Unsupervised, bidirectional hierarchical cluster analysis of lung, kidney, and spleen immune pathway transcriptome
data using the Euclidean distance method with average linkage. All genes differentially expressed in any one of the tissue types were included in the heatmap, which is
colored by the log2 ratio as calculated with respect to average expression in time-matched vehicle controls. (D) Heatmaps depicting either global or directed
significance scores for immune-related pathways (see Materials and Methods for details on calculation of significance scores).

FIGURE 12 | Gene expression pathway Z scores for lung, kidney or spleen tissues obtained 13 weeks post cSiO2 instillation. (A) Heatmap depicts individual pathway
Z scores of each immune pathway for lung, kidney, or spleen tissues obtained from mice 13 weeks post instillation with cSiO2 (four weekly doses) or the
corresponding tissue-matched vehicle (VEH) control. (B) Pathway Z scores are presented as Tukey box-plots (n = 8) for select immune pathways of interest. **p <
0.01; and ***p < 0.001 compared to time-matched vehicle control as determined by the non-parametric Wilcoxon test.

also highly expressed in the lungs of cSiO2 -exposed mice
with similar effects being observed in the kidney. Notably,
immune cell profiling revealed that both exhausted CD8

Chemokines that recruit and direct the position of
activated T-cells, namely Cxcl9, Cxcl10, Cxcl11, and Cxcl16,
and receptors for these chemokines, Cxcr3 and Cxcr6, were
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FIGURE 13 | Tissue comparison of significant differentially expressed genes associated with immune response in lung, kidney or spleen of mice 13 weeks post
instillation with cSiO2 . Gene expression data for (A) innate, (B) adaptive, (C) B-cell functions, (D) T-cell functions, (E) chemokines & receptors, (F) cytokines &
receptors, and (G) interferon pathways were calculated as the log2 ratio of expression values for cSiO2 -treated mice with respect to tissue-matched vehicle controls.
For each pathway of interest, a heatmap with unsupervised clustering (Euclidian distance method) is shown for all genes identified as significantly differentially
expressed (BH q < 0.05, log2 ratio >1 or <−1) in any one of the indicated tissues. The mean log2 ratio values ± SEM for selected genes of interest are also shown
for each panel. Note that some genes are associated with multiple immune response pathways, and thus, these genes appear in multiple panels.

(lung, kidney, spleen) and regulatory T cells (lung, spleen)
were upregulated in mice treated with cSiO2 (Figures 9, 14).
These T cell phenotypes are associated with downregulation
of the immune response and increased numbers have been
associated with lupus and other autoimmune diseases (43, 44).
Thus, their increased numbers observed here following cSiO2
exposure likely reflect compensatory mechanisms to limit
autoimmune pathogenesis.
Frontiers in Immunology | www.frontiersin.org

Genes activated by the Type I and type II IFN constitute
the “IFN signature,” which is evident in 65% of patients with
lupus and which correlates strongly with disease severity (45, 46).
The panel of genes used to define the IFN signature varies by
laboratory; however, we observed striking overlap in the IFN
signature described by Li et al. (47). Type I IFNs (i.e., IFNα and IFN-β) have been established to be pathogenic in lupus
[reviewed in Crow (48)]. The main cellular source of Type I
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FIGURE 14 | Cell type profiling in lung, kidney and spleen tissues in mice 13 weeks post instillation with cSiO2 . Data shown are the log2 cell type scores for lung,
kidney and spleen tissues obtained 13 weeks after four weekly instillations with cSiO2 or saline vehicle (VEH). Scores may be compared within a cell type for each
tissue to infer differences in abundance, but comparisons across cell types are not appropriate for this method of quantitation. *p < 0.05; **p < 0.01; and ***p <
0.001 compared to dosing-matched vehicle control as determined by the non-parametric Wilcoxon test.

consistent with a possible pathogenic role for type I and/or type
II IFN in cSiO2 -triggered autoimmunity.
The IL-1 superfamily is a key component of the innate
immune system and functions to rapidly initiate inflammatory
responses following toxic stimuli via several mechanisms.
Consistent with the known actions of cSiO2 and other
particles [reviewed in Sayan and Mossman (60)], Il1a, Il1b, the
decoy receptor Il1r2, and the receptor antagonist, Il1rn, were
upregulated by exposure to cSiO2 in lungs of NZBWF1 mice.
Dying cells release IL-1α, which serves as an alarmin to alert
the immune system of an inflammatory stimulus. Cells dying
by pyroptosis in an NLRP3 inflammasome-dependent manner
release IL-1β by way of caspase-1 activation. Caspase-1, IL1 β and interleukin 1 receptor associated kinase 3 (IRAK3)
were upregulated in the kidneys of cSiO2 -treated NZBWF1
mice in parallel with IL-1β in this study. Consistent with our
findings, aberrant IL-1 signaling and inflammasome activation is
suspected to contribute to the pathogenesis of ADs such as lupus
[reviewed in Kahlenberg and Kaplan (61)].

IFN is plasmacytoid dendritic cells, which are dependent on
IRF4 activation of TLR7/9 (49, 50). Interestingly, NanoString
immune cell profiling indicated that increased dendritic cells
were evident in lungs, kidneys, and spleens of cSiO2 -treated mice.
Additionally, the aforementioned genes were upregulated in lung
(Irf4) and kidney (Tlr7/9) following cSiO2 exposure. Both have
been widely implicated in autoimmunity (50) and, of particular
relevance here, in ELS during pristane-induced autoimmunity
(51). Finally, exogenous administration of IFN-α to NZBWF1
mice accelerated disease onset (52, 53) and decreased the
efficacy of pharmacological interventions (54). Type II IFN (i.e.,
IFN-γ) has also been implicated in lupus (55–57). Secreted
predominately by NK and T-cells, IFN-γ heightened adaptive
immunity by increased antigen presentation through enhanced
expression of MHC II molecules (58) and immunoglobulin
production (57). Exogenous administration of IFN-γ to lupusprone NZBWF1 mice accelerated glomerulonephritis (59);
whereas IFN-γ receptor deletion attenuated renal injury and
autoantibody generation (52). Collectively, our findings are
Frontiers in Immunology | www.frontiersin.org
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transcriptomic profiling in whole tissue homogenates restricts
the interpretation of results because mRNA signatures cannot be
selectively attributed to a given cell type. Nevertheless, the targets
discovered herein can be employed as endpoints in future studies
that perform mRNA analyses on isolated populations obtained by
cell sorting, cell separation columns, or laser dissection of lesions
of interest from formalin-fixed paraffin sections (18).

Other genes for cytokines and cytokine receptors that
potentially mediate formation and maintenance of lymphoid
tissues were upregulated in lungs, spleen and kidney of
cSiO2 -treated mice. These included Lta (lymphotoxin-α), Il21,
Il21r, Il6, Tnfsf11 (RANKL), Tnfrsf11a (RANK or TRANCE).
Lymphotoxin-α, otherwise known as TNF-β, is induced by IL21 and is critical to formation of lymphoid tissues (62). Mice
deficient in lymphotoxin-α or RANKL fail to properly develop
lymph nodes and Peyer’s patches (63, 64). IL-21/IL-21R blockade
is associated with decreased IL-6 and autoantibody production
and has shown positive effects in preclinical trials in murine
models of lupus and rheumatoid arthritis (65, 66).
Upregulation of genes for adhesion molecules that facilitate
cellular infiltration are commonly observed in renal biopsies
from individuals with lupus nephritis (67–69). Interestingly,
expression of genes coding for adhesion were elevated in lupusprone mice. Specifically, a number of adhesion molecule genes
upregulated in the kidney by cSiO2 exposure are expressed
by infiltrating lymphocytes (Itga4, Itgal) and by endothelial
cells (e.g., Sele, Selplg, Vcam1, Icam1). These might collectively
promote cellular infiltration and facilitate enhanced development
of glomerulonephritis in cSiO2 -treated NZBWF1 mice. It should
be noted that ELS were negatively associated with adhesion
molecule expression at 13 weeks post instillation (15).
Interestingly, cell cycle gene expression was negatively
associated with features of ELS, notably lymphoid aggregates
containing CD3+ and CD45R+ cells, at 5 weeks post instillation
(Figure 10). Ectopic lymphoid neogenesis might have suppressed
active cell proliferation until additional stimuli trigger their reactivation. In addition, genes associated with cancer progression
(e.g., Vegfr2, Angpt2, and Kdr) were suppressed at 9 and 13
weeks post instillation. This may reflect the canon of immune
surveillance and disease development: loss of immune tolerance
results in autoimmunity, whereas overt immune tolerance results
in cancer progression. In this case, active loss of tolerance (as
occurs in our model of cSiO2 -triggered lupus) would effectively
suppress pathways key to cancer progression.
cSiO2 instillation induced large changes in immune genes
in the lung and kidney, whereas responses in the spleen were
relatively modest. Lung and kidney typically do not contain many
immune cells, and the majority of cells that do persist within
these tissues during inflammation are activated. Conversely,
the spleen from these mice contain many more non-activated
cells compared to the other two tissues which may dilute out
the expression of inflammatory genes. Hence, one limitation of
comparing differences in cell-specific genes among the tissues is
that differences may be skewed due to drastic alterations in the
number of activated to non-activated cells within each tissue.
Another limitation of this investigation is that targeted
multiplex approaches, such as NanoString, focus on a subset of
genes and, thus, do not capture genome-wide changes in mRNA
abundance (20). As a result, analytical approaches designed for
discovery, such as gene ontology, have limited utility in the
identification of novel enriched genes. However, since we focused
on immune pathways, a targeted approach was appropriate,
as this method improves statistical power by querying a
substantially smaller gene set. In addition, we recognize that
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CONCLUSION
Taken together, the early and dramatic impact of cSiO2 exposure
on immune gene expression in the lower respiratory tract
promoted the establishment of the lung as the central nexus
for launching systemic autoimmunity. Signatures consistent with
persistent recruitment of neutrophils, monocytes/macrophages,
lymphocytes, and antigen-presenting cells, including dendritic
cells, were identified herein, implying that both innate and
adaptive immune systems contribute largely to the onset
and progression of cSiO2 -triggered autoimmunity. Future
perspectives should include elucidation of the underlying modes
of action of cSiO2 in alveolar macrophages and neutrophils, two
early responders to particles in the lung, as well as identifying
novel interventions against this occupational toxicant.
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